Landscape Capital Management L.L.C. Takes $1.79 Million Position in Haleon plc (NYSE:HLN)

Landscape Capital Management L.L.C. bought a new position in Haleon plc (NYSE:HLN) in the 3rd quarter, Holdings Channel reports. The fund bought 169,531 shares of the company’s stock, valued at approximately $1,794,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blair William & Co. IL raised its position in shares of Haleon by 114.9% during the 1st quarter. Blair William & Co. IL now owns 33,429 shares of the company’s stock valued at $284,000 after purchasing an additional 17,877 shares during the period. O Shaughnessy Asset Management LLC raised its holdings in Haleon by 94.0% during the first quarter. O Shaughnessy Asset Management LLC now owns 43,766 shares of the company’s stock valued at $372,000 after acquiring an additional 21,202 shares during the period. Lake Street Advisors Group LLC lifted its position in shares of Haleon by 61.5% in the first quarter. Lake Street Advisors Group LLC now owns 22,884 shares of the company’s stock valued at $198,000 after acquiring an additional 8,715 shares in the last quarter. EP Wealth Advisors LLC boosted its stake in shares of Haleon by 26.1% in the first quarter. EP Wealth Advisors LLC now owns 22,573 shares of the company’s stock worth $192,000 after acquiring an additional 4,679 shares during the period. Finally, Axxcess Wealth Management LLC grew its position in shares of Haleon by 138.0% during the first quarter. Axxcess Wealth Management LLC now owns 44,824 shares of the company’s stock worth $381,000 after purchasing an additional 25,988 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

HLN has been the subject of several recent analyst reports. UBS Group upgraded Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. Morgan Stanley boosted their target price on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a report on Friday, September 20th. Berenberg Bank assumed coverage on shares of Haleon in a research note on Tuesday, August 6th. They issued a “buy” rating on the stock. Finally, The Goldman Sachs Group downgraded shares of Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $10.95.

Haleon Price Performance

Haleon stock opened at $9.56 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80. The firm’s fifty day moving average is $10.03 and its 200 day moving average is $9.37. The company has a market cap of $43.25 billion, a price-to-earnings ratio of 28.10, a PEG ratio of 2.86 and a beta of 0.30.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.